Home
NewsNewsSmart IUD to track uterus in real-time is being worked upon by Verso Biosense, which will help with data that has in the past been pretty hard to get, offering continuous intrauterine insights for better reproductive care.
Verso Biosense, which is based out of Oxfordshire, is working on an intrauterine device - IUD to track the uterus in real-time that can measure important physiological conditions like temperature and oxygen levels consistently for several days. The company says the technology could help scientists learn more about one of the least known organs in the human body by giving them data that has been difficult to get in the past.
The smart IUD to track the uterus in real-time looks like a regular IUD, but it has tiny sensors inside that collect data all the time and send it wirelessly for evaluation. The device is being looked into as a way to monitor uterine conditions in women who have had unsuccessful IVF cycles in order to find the circumstances that give embryos the best chance of a successful implantation.
Kate Rowley, the CEO of Verso Biosense, said, “Medicine has made extraordinary advances in many fields, but the uterus is still something of a black box. Our goal is to shine a light inside the uterine environment and gather the data needed to truly understand how it functions. Once we can see what’s happening in real time, we can start developing far more personalized and effective treatments.”
There are studies in science demonstrating that elements like temperature and oxygen levels can affect how embryos grow, but it has been very difficult to measure such factors directly inside the uterus. Verso Biosense wants to create large-scale datasets over time that show patterns across menstrual cycles. This kind of long-term data is not there as of now.
As per Rowley, “To really understand reproductive health, we need longitudinal data – potentially monitoring biomarkers over months or years. That’s a huge engineering challenge when the device itself is extremely small.”
In the years to come, intrauterine monitoring could be used for more than just fertility research. It could also be used to study endometriosis, PCOS, uterine cancers, perimenopause, and menopause. This would add a new layer of data to conditions that are still not well-defined because there is no direct physiological measurement.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
Alife Health secured CE Mark approval for its AI-powered embryo selection tool, Embryo Predict, under EU MDR, expanding its fertility technology presence across Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
South Korean couples travel abroad for gender-selective IVF procedures, spending dollars in Thailand and Cyprus due to domestic legal restrictions on choosing a baby's sex.
As more families pursue fertility treatments, IVF CRYO urges greater transparency and safety in better Safe Embryos and Eggs Shipping across the U.S.
China sees a rise in advanced maternal age In Vitro Fertilization, driven by BaseCare Medical’s AI undisturbed culture system that improves embryo quality and clinical pregnancy rates, especially with PGT. Localized AI-assisted solutions position BaseCare as a leader in smart, precision reproduction technology for older IVF patients.
